{"id":"W4399122701","doi":"10.1016/j.ejcskn.2024.100143","title":"A phase 3 study of the efficacy, safety, and pharmacokinetics profile of subcutaneous vs intravenous nivolumab + relatlimab fixed-dose combination in previously untreated metastatic or unresectable melanoma (RELATIVITY-127)","year":2024,"lang":"en","type":"article","venue":"EJC Skin Cancer","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Hôpital de l'Enfant-Jésus","funders":"","keywords":"Nivolumab; Medicine; Pharmacokinetics; Safety profile; Metastatic melanoma; Melanoma; Oncology; Pharmacology; Internal medicine; Anesthesia; Adverse effect; Cancer; Immunotherapy; Cancer research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002124338,0.002006125,0.003010283,0.0006939989,0.0005955251,0.001517869,0.001115913,0.001452419,0.004049231],"category_scores_gemma":[0.001242581,0.0009351412,0.003003111,0.0006000724,0.001617865,0.001166888,0.0003944983,0.005878437,0.001273311],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00149133,"about_ca_system_score_gemma":0.00255078,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002471671,"about_ca_topic_score_gemma":0.003874196,"domain_scores_codex":[0.9992371,0.00031429,0.00002218049,0.0001610943,0.00006577637,0.0001996311],"domain_scores_gemma":[0.9989536,0.000180383,0.0001713953,0.000140384,0.00005397224,0.0005002953],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8247532,0.09775673,0.001796326,0.0002868263,0.001361827,0.0001217754,0.0002504868,0.002250874,0.03191299,0.0002722122,0.002100485,0.03713637],"study_design_scores_gemma":[0.4355563,0.5547464,0.004047826,0.00001326744,0.0004333795,0.000110114,0.00005256532,0.001125203,0.002764494,0.0001853181,0.0009297109,0.00003549476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943968,0.0007344535,0.0006138687,0.0002825911,0.0001751486,0.001355712,0.001118888,0.00009849283,0.001224006],"genre_scores_gemma":[0.9886739,0.0009310872,0.002127588,0.0006949998,0.0002269397,0.002011339,0.002104821,0.00008771844,0.003141589],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004049231,"threshold_uncertainty_score":0.01354605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02617570707622666,"score_gpt":0.3528993156838462,"score_spread":0.3267236086076196,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}